Phar 232 Exam 2 Lab Values

Albumin

3.4-4.7 g/dL

Bilirubin Total

0.1-1.2 mg/dL

Bilirubin INdirect

0.2-0.7 mg/dL

Bilirubin Direct

0.1-0.4 mg/dL

Alkaline Phosphatase (sensitive not specific)

41-133 IU/L

5’ nucleotidase (high specificity)

elevated in Cholestasis and rarely elevated in non-heaptic disease

GGT or GGTP or YGT (high sensitivity poor specificity)

9-85 IU/L

AST/ALT

0-35 IU/L

Hepatocellular injury

AST/ALT»»ALP

Cholestasis

ALP > > AST/ALT

Ammonia

11-35 mcmol/L

TIBC

250-460 mg/dL

Transferrin Sat % = serum iron/TIBC

30-50%

MCH

27-33 pg

MCHC

31-36 g/dL

HCT female

35-45%

HCT Male

39-49%

Hg Female

12-15.5 g/dL

Hg Male

13.6-17.5 g/dL

MCV

80-100 um³

Ferritin Female

12-300 ng/ml

Ferritin Male

30-500 ng/mL

Transferrin

200-400 mg/dL

Reticulocyte Count

0.5-1.5% of RBC Count

RDW

9-14.5%

RBC Male

4.3-6 × 10^6 /uL

RBC Female

3.5-5.5 × 10^6 /uL

Vitamin B12

180-1000 pg/mL

JVP normal

6-8 cam above RA

JVP Abnormal/Elevated

>9cm above RA

Ejection Fraction

50-70%

HDL

>35 mg/dL

LDL

<130 mg/dL

Total Cholesterol

<200 mg/dL

Triglycerides (fasting)

<165 mg/dL

C-reactive protein (hs-CRP)

<1mg/L

Creatine Kinase

20-200 IU/L

A1C

4-5.6%

Glucose (fasting)

60-110 mg/dL

Glucose Post-prandial

<140mg/dL

Glucose Critical

<40 and >500 mg/dL

Goal of Therapy GOT

6.5 to 8%

Preprandial Capillary plasma glucose ADA GOT

80-130mg/dL

Post-Prandial capillary plasma glucose (ADA GOT)

<180 mg/dL

WBC

4.5 to 11 ×10³ cells/uL

Bands

0-5%

Neutrophils (PMN/Segs)

50-70%

Eosinophils

0-4%

Basophils

0-1%

Monocytes

2-6%

Lymphocytes

20-40%

WBC critical

<1.5

Triglyceride

<165 mg/dL

Granulocyte

1.8-6.6 ×10³/uL

Leukocyte count

3.8-9.8×10³/uL

Lymphocyte count

1.2-3.3×10³/uL